Skip to main content
Premium Trial:

Request an Annual Quote

VBI Teams With Brazilian Institute to Develop Infectious Disease Products

NEW YORK, May 3 (GenomeWeb News) - The Virginia Bioinformatics Institute and a Brazilian health institute yesterday said they plan to develop a wide range of medical products and technologies.

 

The initial three-year alliance calls for the VBI and the Oswaldo Cruz Foundation to "facilitate the development of" drugs, vaccines, diagnostics, and "other technologies" for infectious diseases, including dengue fever, hepatitis C, HIV/AIDS, influenza, malaria, and pneumonia.

 

Details of the agreement were not disclosed.

 

FIOCRUZ, based in Rio de Janeiro, has expertise in biology, medicine, and the epidemiology of infectious diseases, while VBI is known for its genomics, proteomics, and bioinformatics tools and data.

The Scan

Highly Similar

Researchers have uncovered bat viruses that are highly similar to SARS-CoV-2, according to Nature News.

Gain of Oversight

According to the Wall Street Journal, the Biden Administration is considering greater oversight of gain-of-function research.

Lasker for mRNA Vaccine Work

The Scientist reports that researchers whose work enabled the development of mRNA-based vaccines are among this year's Lasker Award winners

PLOS Papers on Causal Variant Mapping, Ancient Salmonella, ALK Fusion Test for NSCLC

In PLOS this week: MsCAVIAR approach to map causal variants, analysis of ancient Salmonella, and more.